FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Martha Vaughan

Research Profile

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Xiaoyan Shen; Angel M Aponte; Eric M Billings; Chun-Chun Li; Joel Moss; Rong-Fong Shen; Martha Vaughan
Brefeldin A-inhibited ADP-ribosylation factor activator BIG2 regulates cell migration via integrin β1 cycling and actin remodeling.
Chun-Chun Li; Joel Moss; Ryoiti Kiyama; Jean-Cheng Kuo; Clare M Waterman; Martha Vaughan
Effects of brefeldin A-inhibited guanine nucleotide-exchange (BIG) 1 and KANK1 proteins on cell polarity and directed migration during wound healing.
Victor Meza-Carmen; Joel Moss; Gustavo Pacheco-Rodriguez; D Michael Payne; Mario Stylianou; Chiara Donati; Souheil El-Chemaly; Gi Soo Kang; Jiro Kato; Alessandro Vichi; Chun-Yi Zhang; Martha Vaughan
Regulation of growth factor receptor degradation by ADP-ribosylation factor domain protein (ARD) 1.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Martha Vaughan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Xiaoyan Shen; Angel M Aponte; Eric M Billings; Chun-Chun Li; Joel Moss; Rong-Fong Shen; Martha Vaughan
Brefeldin A-inhibited ADP-ribosylation factor activator BIG2 regulates cell migration via integrin β1 cycling and actin remodeling.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(36):14464-9.
2011: Chun-Chun Li; Joel Moss; Ryoiti Kiyama; Jean-Cheng Kuo; Clare M Waterman; Martha Vaughan
Effects of brefeldin A-inhibited guanine nucleotide-exchange (BIG) 1 and KANK1 proteins on cell polarity and directed migration during wound healing.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(48):19228-33.
2011: Victor Meza-Carmen; Joel Moss; Gustavo Pacheco-Rodriguez; D Michael Payne; Mario Stylianou; Chiara Donati; Souheil El-Chemaly; Gi Soo Kang; Jiro Kato; Alessandro Vichi; Chun-Yi Zhang; Martha Vaughan
Regulation of growth factor receptor degradation by ADP-ribosylation factor domain protein (ARD) 1.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(26):10454-9.
2009: Ermanno Puxeddu; Marina Uhart; Chun-Chun Li; Faiyaz Ahmad; Gustavo Pacheco-Rodriguez; Vincent C Manganiello; Joel Moss; Martha Vaughan
Interaction of phosphodiesterase 3A with brefeldin A-inhibited guanine nucleotide-exchange proteins BIG1 and BIG2 and effect on ARF1 activity.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(15):6158-63.
2008: Xiaoyan Shen; Victor Meza-Carmen; Ermanno Puxeddu; Guanghui Wang; Joel Moss; Martha Vaughan
Interaction of brefeldin A-inhibited guanine nucleotide-exchange protein (BIG) 1 and kinesin motor protein KIF21A.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(48):18788-93.
2008: Aminul Islam; Heather Jones; Toyoko Hiroi; Jonathan Lam; Jing Zhang; Joel Moss; Martha Vaughan; Stewart J Levine
cAMP-dependent protein kinase A (PKA) signaling induces TNFR1 exosome-like vesicle release via anchoring of PKA regulatory subunit RIIbeta to BIG2.
The Journal of biological chemistry 2008;283(37):25364-71.
2008: Philip Ian Padilla; Marina Uhart; Gustavo Pacheco-Rodriguez; Brenda A Peculis; Joel Moss; Martha Vaughan
Association of guanine nucleotide-exchange protein BIG1 in HepG2 cell nuclei with nucleolin, U3 snoRNA, and fibrillarin.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(9):3357-61.
2008: Carmen Citterio; Alessandro Vichi; Gustavo Pacheco-Rodriguez; Angel M Aponte; Joel Moss; Martha Vaughan
Unfolded protein response and cell death after depletion of brefeldin A-inhibited guanine nucleotide-exchange protein GBF1.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(8):2877-82.
2007: Aminul Islam; Xiaoyan Shen; Toyoko Hiroi; Joel Moss; Martha Vaughan; Stewart J Levine
The brefeldin A-inhibited guanine nucleotide-exchange protein, BIG2, regulates the constitutive release of TNFR1 exosome-like vesicles.
The Journal of biological chemistry 2007;282(13):9591-9.
2007: Fuminobu Kuroda; Joel Moss; Martha Vaughan
Regulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) and BIG2 activity via PKA and protein phosphatase 1gamma.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(9):3201-6.
2007: Xiaoyan Shen; Myoung-Soon S Hong; Joel Moss; Martha Vaughan
BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein, is required for correct glycosylation and function of integrin beta1.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(4):1230-5.
2006: Toyoko Hiroi; Akimasa Someya; Walter Thompson; Joel Moss; Martha Vaughan
GEP100/BRAG2: activator of ADP-ribosylation factor 6 for regulation of cell adhesion and actin cytoskeleton via E-cadherin and alpha-catenin.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(28):10672-7.
2006: Xiaoyan Shen; Kai-Feng Xu; Qingyuan Fan; Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
Association of brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2) with recycling endosomes during transferrin uptake.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(8):2635-40.
2006: Carmen Citterio; Heather D Jones; Gustavo Pacheco-Rodriguez; Aminul Islam; Joel Moss; Martha Vaughan
Effect of protein kinase A on accumulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) in HepG2 cell nuclei.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(8):2683-8.
2005: Kai-Feng Xu; Xiaoyan Shen; Hewang Li; Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
Interaction of BIG2, a brefeldin A-inhibited guanine nucleotide-exchange protein, with exocyst protein Exo70.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(8):2784-9.
2005: Alessandro Vichi; D Michael Payne; Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
E3 ubiquitin ligase activity of the trifunctional ARD1 (ADP-ribosylation factor domain protein 1).
Proceedings of the National Academy of Sciences of the United States of America 2005;102(6):1945-50.
2005: Alessandro Vichi; Joel Moss; Martha Vaughan
ADP-ribosylation factor domain protein 1 (ARD1), a multifunctional protein with ubiquitin E3 ligase, GAP, and ARF domains.
Methods in enzymology 2005;404():195-206.
2005: Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
Cytohesin-1: structure, function, and ARF activation.
Methods in enzymology 2005;404():184-95.
2005: Heather D Jones; Joel Moss; Martha Vaughan
BIG1 and BIG2, brefeldin A-inhibited guanine nucleotide-exchange factors for ADP-ribosylation factors.
Methods in enzymology 2005;404():174-84.
2004: Philip Ian Padilla; Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
Nuclear localization and molecular partners of BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(9):2752-7.
2003: Philip Ian Padilla; Min-Ju Chang; Gustavo Pacheco-Rodriguez; Ronald Adamik; Joel Moss; Martha Vaughan
Interaction of FK506-binding protein 13 with brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1): effects of FK506.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(5):2322-7.
2003: Hewang Li; Ronald Adamik; Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
Protein kinase A-anchoring (AKAP) domains in brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2).
Proceedings of the National Academy of Sciences of the United States of America 2003;100(4):1627-32.
2003: Elisabetta Meacci; Francesca Nuti; Serena Catarzi; Valeria Vasta; Chiara Donati; Sylvain Bourgoin; Paola Bruni; Joel Moss; Martha Vaughan
Activation of phospholipase D by bradykinin and sphingosine 1-phosphate in A549 human lung adenocarcinoma cells via different GTP-binding proteins and protein kinase C delta signaling pathways.
Biochemistry 2003;42(2):284-92.
2002: Pingtao Tang; Tammy P Cheng; Davide Agnello; Chang-You Wu; Bruce D Hissong; Wendy T Watford; Hyun-Jong Ahn; Jérôme Galon; Joel Moss; Martha Vaughan; John O'Shea; Massimo Gadina
Cybr, a cytokine-inducible protein that binds cytohesin-1 and regulates its activity.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(5):2625-9.
2002: Joel Moss; Martha Vaughan
Cytohesin-1 in 2001.
Archives of biochemistry and biophysics 2002;397(2):156-61.
2002: Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
ARF-directed guanine-nucleotide-exchange (GEP) proteins.
Methods in molecular biology (Clifton, N.J.) 2002;189():181-9.
2002: Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
BIG1 and BIG2: brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors.
Methods in enzymology 2002;345():397-404.
2001: A Someya; M Sata; Kazuyo Takeda; Gustavo Pacheco-Rodriguez; Victor J Ferrans; Joel Moss; Martha Vaughan
ARF-GEP(100), a guanine nucleotide-exchange protein for ADP-ribosylation factor 6.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(5):2413-8.
2001: Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
Preparation and assay of recombinant ADP-ribosylation factor-like protein-1 (ARL1).
Methods in enzymology 2001;329():424-8.
2001: Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
Isolation, cloning, and characterization of brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factor.
Methods in enzymology 2001;329():300-6.
2000: N Vitale; V J Ferrans; Joel Moss; Martha Vaughan
Identification of lysosomal and Golgi localization signals in GAP and ARF domains of ARF domain protein 1.
Molecular and cellular biology 2000;20(19):7342-52.
2000: N Vitale; Gustavo Pacheco-Rodriguez; Victor J Ferrans; William K Riemenschneider; Joel Moss; Martha Vaughan
Specific functional interaction of human cytohesin-1 and ADP-ribosylation factor domain protein (ARD1).
The Journal of biological chemistry 2000;275(28):21331-9.
2000: Nicolas Vitale; WA Patton; Joel Moss; Martha Vaughan; Robert J Lefkowitz; Richard T Premont
GIT proteins, A novel family of phosphatidylinositol 3,4, 5-trisphosphate-stimulated GTPase-activating proteins for ARF6.
The Journal of biological chemistry 2000;275(18):13901-6.
2000: R Yamaji; Ronald Adamik; Kazuyo Takeda; A Togawa; Gustavo Pacheco-Rodriguez; Victor J Ferrans; Joel Moss; Martha Vaughan
Identification and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(6):2567-72.
2000: M Ogasawara; S C Kim; Ronald Adamik; A Togawa; Victor J Ferrans; Kazuyo Takeda; M Kirby; Joel Moss; Martha Vaughan
Similarities in function and gene structure of cytohesin-4 and cytohesin-1, guanine nucleotide-exchange proteins for ADP-ribosylation factors.
The Journal of biological chemistry 2000;275(5):3221-30.
1999: Elisabetta Meacci; Valeria Vasta; JP Moorman; DA Bobak; Paola Bruni; Joel Moss; Martha Vaughan
Effect of Rho and ADP-ribosylation factor GTPases on phospholipase D activity in intact human adenocarcinoma A549 cells.
The Journal of biological chemistry 1999;274(26):18605-12.
1999: N Morinaga; Ronald Adamik; Joel Moss; Martha Vaughan
Brefeldin A inhibited activity of the sec7 domain of p200, a mammalian guanine nucleotide-exchange protein for ADP-ribosylation factors.
The Journal of biological chemistry 1999;274(25):17417-23.
1999: Gustavo Pacheco-Rodriguez; WA Patton; Ronald Adamik; H S Yoo; Fang-Jen S Lee; G F Zhang; Joel Moss; Martha Vaughan
Structural elements of ADP-ribosylation factor 1 required for functional interaction with cytohesin-1.
The Journal of biological chemistry 1999;274(18):12438-44.
1999: A Togawa; N Morinaga; M Ogasawara; Joel Moss; Martha Vaughan
Purification and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors.
The Journal of biological chemistry 1999;274(18):12308-15.
1999: M Sata; Joel Moss; Martha Vaughan
Structural basis for the inhibitory effect of brefeldin A on guanine nucleotide-exchange proteins for ADP-ribosylation factors.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(6):2752-7.
1999: Joel Moss; Martha Vaughan
Activation of toxin ADP-ribosyltransferases by eukaryotic ADP-ribosylation factors.
Molecular and cellular biochemistry 1999;193(1-2):153-7.
1999: Linda A Stevens; Joel Moss; Martha Vaughan; M Pizza; R Rappuoli
Effects of site-directed mutagenesis of Escherichia coli heat-labile enterotoxin on ADP-ribosyltransferase activity and interaction with ADP-ribosylation factors.
Infection and immunity 1999;67(1):259-65.
1998: Richard T Premont; Audrey Claing; Nicolas Vitale; Jennifer L R Freeman; Julie A Pitcher; WA Patton; Joel Moss; Martha Vaughan; Robert J Lefkowitz
beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(24):14082-7.
1998: Gustavo Pacheco-Rodriguez; Elisabetta Meacci; N Vitale; Joel Moss; Martha Vaughan
Guanine nucleotide exchange on ADP-ribosylation factors catalyzed by cytohesin-1 and its Sec7 domain.
The Journal of biological chemistry 1998;273(41):26543-8.
1998: Joel Moss; Martha Vaughan
Molecules in the ARF orbit.
The Journal of biological chemistry 1998;273(34):21431-4.
1998: S C Tsai; Ronald Adamik; J X Hong; Joel Moss; Martha Vaughan; H Kanoh; J H Exton
Effects of arfaptin 1 on guanine nucleotide-dependent activation of phospholipase D and cholera toxin by ADP-ribosylation factor.
The Journal of biological chemistry 1998;273(33):20697-701.
1998: N Vitale; Koji Horiba; Victor J Ferrans; Joel Moss; Martha Vaughan
Localization of ADP-ribosylation factor domain protein 1 (ARD1) in lysosomes and Golgi apparatus.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(15):8613-8.
1998: Martha Vaughan
G protein-coupled receptors minireview series.
The Journal of biological chemistry 1998;273(28):17297.
1998: J X Hong; Fang-Jen S Lee; WA Patton; Chen-Yong Lin; Joel Moss; Martha Vaughan
Phospholipid- and GTP-dependent activation of cholera toxin and phospholipase D by human ADP-ribosylation factor-like protein 1 (HARL1).
The Journal of biological chemistry 1998;273(25):15872-6.
1998: M Sata; Julie G Donaldson; Joel Moss; Martha Vaughan
Brefeldin A-inhibited guanine nucleotide-exchange activity of Sec7 domain from yeast Sec7 with yeast and mammalian ADP ribosylation factors.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(8):4204-8.
1998: N Vitale; Joel Moss; Martha Vaughan
Molecular characterization of the GTPase-activating domain of ADP-ribosylation factor domain protein 1 (ARD1).
The Journal of biological chemistry 1998;273(5):2553-60.
1998: Martha Vaughan
Signaling by heterotrimeric G proteins minireview series.
The Journal of biological chemistry 1998;273(2):667-8.
1997: Fang-Jen S Lee; Chun-Fang Huang; W L Yu; Leh-Miauh Buu; Chen-Yong Lin; M C Huang; Joel Moss; Martha Vaughan
Characterization of an ADP-ribosylation factor-like 1 protein in Saccharomyces cerevisiae.
The Journal of biological chemistry 1997;272(49):30998-1005.
1997: N Morinaga; Joel Moss; Martha Vaughan
Cloning and expression of a cDNA encoding a bovine brain brefeldin A-sensitive guanine nucleotide-exchange protein for ADP-ribosylation factor.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(24):12926-31.
1997: N Vitale; Joel Moss; Martha Vaughan
Characterization of a GDP dissociation inhibitory region of ADP-ribosylation factor domain protein ARD1.
The Journal of biological chemistry 1997;272(40):25077-82.
1997: Fang-Jen S Lee; WA Patton; Chen-Yong Lin; Joel Moss; Martha Vaughan; ND Goldman; C Syin
Identification and characterization of an ADP-ribosylation factor in Plasmodium falciparum.
Molecular and biochemical parasitology 1997;87(2):217-23.
1997: Elisabetta Meacci; S C Tsai; Ronald Adamik; Joel Moss; Martha Vaughan
Cytohesin-1, a cytosolic guanine nucleotide-exchange protein for ADP-ribosylation factor.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(5):1745-8.
1997: N Vitale; Joel Moss; Martha Vaughan
Interaction of the GTP-binding and GTPase-activating domains of ARD1 involves the effector region of the ADP-ribosylation factor domain.
The Journal of biological chemistry 1997;272(7):3897-904.
1997: Martha Vaughan; Joel Moss
Activation of toxin ADP-ribosyltransferases by the family of ADP-ribosylation factors.
Advances in experimental medicine and biology 1997;419():315-20.
1996: N Morinaga; S C Tsai; Joel Moss; Martha Vaughan
Isolation of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP ribosylation factor (ARF) 1 and ARF3 that contains a Sec7-like domain.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(23):12856-60.
1996: M Ding; N Vitale; S C Tsai; Ronald Adamik; Joel Moss; Martha Vaughan
Characterization of a GTPase-activating protein that stimulates GTP hydrolysis by both ADP-ribosylation factor (ARF) and ARF-like proteins. Comparison to the ARD1 gap domain.
The Journal of biological chemistry 1996;271(39):24005-9.
1996: C M Lee; Linda A Stevens; H C Hsu; S C Tsai; Y T Lee; Joel Moss; Martha Vaughan
Expression in human endothelial cells of ADP-ribosylation factors, 20-kDa guanine nucleotide-binding proteins involved in the initiation of vesicular transport.
Journal of molecular and cellular cardiology 1996;28(9):1911-20.
1996: S R Price; M S Nightingale; M Tsuchiya; Joel Moss; Martha Vaughan
Interspecies relationships among ADP-ribosylation factors (ARFs): evidence of evolutionary pressure to maintain individual identities.
Molecular and cellular biochemistry 1996;159(1):15-23.
1996: N Vitale; Joel Moss; Martha Vaughan
ARD1, a 64-kDa bifunctional protein containing an 18-kDa GTP-binding ADP-ribosylation factor domain and a 46-kDa GTPase-activating domain.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(5):1941-4.
1996: S C Tsai; Ronald Adamik; Joel Moss; Martha Vaughan
Purification and characterization of a guanine nucleotide-exchange protein for ADP-ribosylation factor from spleen cytosol.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(1):305-9.
1995: J M Justice; J J Murtagh; Joel Moss; Martha Vaughan
Hydrophobicity and subunit interactions of rod outer segment proteins investigated using Triton X-114 phase partitioning.
The Journal of biological chemistry 1995;270(30):17970-6.
1995: Joel Moss; Martha Vaughan
Structure and function of ARF proteins: activators of cholera toxin and critical components of intracellular vesicular transport processes.
The Journal of biological chemistry 1995;270(21):12327-30.
1995: J X Hong; X Zhang; Joel Moss; Martha Vaughan
Isolation of an amino-terminal deleted recombinant ADP-ribosylation factor 1 in an activated nucleotide-free state.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(7):3056-9.
1995: J M Justice; Michael M Bliziotes; Linda A Stevens; Joel Moss; Martha Vaughan
Involvement of N-myristoylation in monoclonal antibody recognition sites on chimeric G protein alpha subunits.
The Journal of biological chemistry 1995;270(12):6436-9.
1995: G F Zhang; WA Patton; Fang-Jen S Lee; Marek Liyanage; J S Han; Sue Goo Rhee; Joel Moss; Martha Vaughan
Different ARF domains are required for the activation of cholera toxin and phospholipase D.
The Journal of biological chemistry 1995;270(1):21-4.
1994: D Massenburg; J S Han; Marek Liyanage; WA Patton; Sue Goo Rhee; Joel Moss; Martha Vaughan
Activation of rat brain phospholipase D by ADP-ribosylation factors 1,5, and 6: separation of ADP-ribosylation factor-dependent and oleate-dependent enzymes.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(24):11718-22.
1994: Catherine Welsh; Joel Moss; Martha Vaughan
ADP-ribosylation factors: a family of approximately 20-kDa guanine nucleotide-binding proteins that activate cholera toxin.
Molecular and cellular biochemistry 1994;138(1-2):157-66.
1994: Fang-Jen S Lee; Linda A Stevens; Linda M Hall; J J Murtagh; Y L Kao; Joel Moss; Martha Vaughan
Characterization of class II and class III ADP-ribosylation factor genes and proteins in Drosophila melanogaster.
The Journal of biological chemistry 1994;269(34):21555-60.
1994: Fang-Jen S Lee; Linda A Stevens; Y L Kao; Joel Moss; Martha Vaughan
Characterization of a glucose-repressible ADP-ribosylation factor 3 (ARF3) from Saccharomyces cerevisiae.
The Journal of biological chemistry 1994;269(33):20931-7.
1994: Catherine Welsh; Joel Moss; Martha Vaughan
Isolation of recombinant ADP-ribosylation factor 6, an approximately 20-kDa guanine nucleotide-binding protein, in an activated GTP-bound state.
The Journal of biological chemistry 1994;269(22):15583-7.
1994: S C Tsai; Ronald Adamik; Joel Moss; Martha Vaughan
Identification of a brefeldin A-insensitive guanine nucleotide-exchange protein for ADP-ribosylation factor in bovine brain.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(8):3063-6.
1994: J X Hong; Randy S Haun; S C Tsai; Joel Moss; Martha Vaughan
Effect of ADP-ribosylation factor amino-terminal deletions on its GTP-dependent stimulation of cholera toxin activity.
The Journal of biological chemistry 1994;269(13):9743-5.
1994: Joel Moss; S C Tsai; Martha Vaughan
Activation of cholera toxin by ADP-ribosylation factors.
Methods in enzymology 1994;235():640-7.
1994: Joel Moss; Randy S Haun; S C Tsai; Catherine Welsh; Fang-Jen S Lee; S R Price; Martha Vaughan
Activation of cholera toxin by ADP-ribosylation factors: 20-kDa guanine nucleotide-binding proteins.
Methods in enzymology 1994;237():44-63.
1993: B C Kunz; K A Muczynski; Catherine Welsh; S J Stanley; S C Tsai; Ronald Adamik; P P Chang; Joel Moss; Martha Vaughan
Characterization of recombinant and endogenous ADP-ribosylation factors synthesized in Sf9 insect cells.
Biochemistry 1993;32(26):6643-8.
1993: Joel Moss; Martha Vaughan
ADP-ribosylation factors, 20,000 M(r) guanine nucleotide-binding protein activators of cholera toxin and components of intracellular vesicular transport systems.
Cellular signalling 1993;5(4):367-79.
1993: J J Murtagh; Fang-Jen S Lee; P Deak; Linda M Hall; L Monaco; C M Lee; Linda A Stevens; Joel Moss; Martha Vaughan
Molecular characterization of a conserved, guanine nucleotide-dependent ADP-ribosylation factor in Drosophila melanogaster.
Biochemistry 1993;32(23):6011-8.
1993: S C Tsai; Ronald Adamik; Randy S Haun; Joel Moss; Martha Vaughan
Effects of brefeldin A and accessory proteins on association of ADP-ribosylation factors 1, 3, and 5 with Golgi.
The Journal of biological chemistry 1993;268(15):10820-5.
1993: K Mishima; M Tsuchiya; M S Nightingale; Joel Moss; Martha Vaughan
ARD 1, a 64-kDa guanine nucleotide-binding protein with a carboxyl-terminal ADP-ribosylation factor domain.
The Journal of biological chemistry 1993;268(12):8801-7.
1993: Randy S Haun; Joel Moss; Martha Vaughan
Characterization of the human ADP-ribosylation factor 3 promoter. Transcriptional regulation of a TATA-less promoter.
The Journal of biological chemistry 1993;268(12):8793-800.
1993: Randy S Haun; S C Tsai; Ronald Adamik; Joel Moss; Martha Vaughan
Effect of myristoylation on GTP-dependent binding of ADP-ribosylation factor to Golgi.
The Journal of biological chemistry 1993;268(10):7064-8.
1993: Joel Moss; S J Stanley; Martha Vaughan; T Tsuji
Interaction of ADP-ribosylation factor with Escherichia coli enterotoxin that contains an inactivating lysine 112 substitution.
The Journal of biological chemistry 1993;268(9):6383-7.
1993: I M Serventi; E Cavanaugh; Joel Moss; Martha Vaughan
Characterization of the gene for ADP-ribosylation factor (ARF) 2, a developmentally regulated, selectively expressed member of the ARF family of approximately 20-kDa guanine nucleotide-binding proteins.
The Journal of biological chemistry 1993;268(7):4863-72.
1993: T Murayama; S C Tsai; Ronald Adamik; Joel Moss; Martha Vaughan
Effects of temperature on ADP-ribosylation factor stimulation of cholera toxin activity.
Biochemistry 1993;32(2):561-6.
1993: Joel Moss; Martha Vaughan
ADP-ribosylation factors: protein activators of cholera toxin.
Progress in nucleic acid research and molecular biology 1993;45():47-65.
1992: Fang-Jen S Lee; Joel Moss; Martha Vaughan
Human and Giardia ADP-ribosylation factors (ARFs) complement ARF function in Saccharomyces cerevisiae.
The Journal of biological chemistry 1992;267(34):24441-5.
1992: S R Price; M S Nightingale; DA Bobak; M Tsuchiya; Joel Moss; Martha Vaughan
Conservation of a 23-kDa human transplantation antigen in mammalian species.
Genomics 1992;14(4):959-64.
1992: K Mishima; S R Price; M S Nightingale; E Kousvelari; Joel Moss; Martha Vaughan
Regulation of ADP-ribosylation factor (ARF) expression. Cross-species conservation of the developmental and tissue-specific alternative polyadenylation of ARF 4 mRNA.
The Journal of biological chemistry 1992;267(33):24109-16.
1992: S C Tsai; Ronald Adamik; Randy S Haun; Joel Moss; Martha Vaughan
Differential interaction of ADP-ribosylation factors 1, 3, and 5 with rat brain Golgi membranes.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(19):9272-6.
1992: S R Price; Catherine Welsh; Randy S Haun; S J Stanley; Joel Moss; Martha Vaughan
Effects of phospholipid and GTP on recombinant ADP-ribosylation factors (ARFs). Molecular basis for differences in requirements for activity of mammalian ARFs.
The Journal of biological chemistry 1992;267(25):17766-72.
1992: J Avigan; J J Murtagh; Linda A Stevens; C W Angus; Joel Moss; Martha Vaughan
Pertussis toxin-catalyzed ADP-ribosylation of G(o) alpha with mutations at the carboxyl terminus.
Biochemistry 1992;31(33):7736-40.
1992: J J Murtagh; M R Mowatt; C M Lee; Fang-Jen S Lee; K Mishima; Theodore E Nash; Joel Moss; Martha Vaughan
Guanine nucleotide-binding proteins in the intestinal parasite Giardia lamblia. Isolation of a gene encoding an approximately 20-kDa ADP-ribosylation factor.
The Journal of biological chemistry 1992;267(14):9654-62.
1992: C M Lee; Randy S Haun; S C Tsai; Joel Moss; Martha Vaughan
Characterization of the human gene encoding ADP-ribosylation factor 1, a guanine nucleotide-binding activator of cholera toxin.
The Journal of biological chemistry 1992;267(13):9028-34.
1992: M W Walker; DA Bobak; S C Tsai; Joel Moss; Martha Vaughan
GTP but not GDP analogues promote association of ADP-ribosylation factors, 20-kDa protein activators of cholera toxin, with phospholipids and PC-12 cell membranes.
The Journal of biological chemistry 1992;267(5):3230-5.
1992: Joel Moss; Martha Vaughan
Activation of cholera toxin by ADP-ribosylation factors, 20-kDa guanine nucleotide-binding proteins.
Current topics in cellular regulation 1992;32():49-72.
1992: I M Serventi; Joel Moss; Martha Vaughan
Enhancement of cholera toxin-catalyzed ADP-ribosylation by guanine nucleotide-binding proteins.
Current topics in microbiology and immunology 1992;175():43-67.
1992: Catherine Welsh; Joel Moss; Martha Vaughan
ADP-ribosylation factor, a guanine nucleotide-binding protein activator of cholera toxin, is isolated in an activated state when expressed as a fusion protein in Escherichia coli.
Transactions of the Association of American Physicians 1992;105():172-6.
1991: S C Tsai; Randy S Haun; M Tsuchiya; Joel Moss; Martha Vaughan
Isolation and characterization of the human gene for ADP-ribosylation factor 3, a 20-kDa guanine nucleotide-binding protein activator of cholera toxin.
The Journal of biological chemistry 1991;266(34):23053-9.
1991: Joel Moss; Martha Vaughan
Activation of cholera toxin and Escherichia coli heat-labile enterotoxins by ADP-ribosylation factors, a family of 20 kDa guanine nucleotide-binding proteins.
Molecular microbiology 1991;5(11):2621-7.
1991: S C Tsai; Ronald Adamik; M Tsuchiya; P P Chang; Joel Moss; Martha Vaughan
Differential expression during development of ADP-ribosylation factors, 20-kDa guanine nucleotide-binding protein activators of cholera toxin.
The Journal of biological chemistry 1991;266(13):8213-9.
1991: S C Tsai; Ronald Adamik; Joel Moss; Martha Vaughan
Guanine nucleotide dependent formation of a complex between choleragen (cholera toxin) a subunit and bovine brain ADP-ribosylation factor.
Biochemistry 1991;30(15):3697-703.
1991: M Tsuchiya; S R Price; S C Tsai; Joel Moss; Martha Vaughan
Molecular identification of ADP-ribosylation factor mRNAs and their expression in mammalian cells.
The Journal of biological chemistry 1991;266(5):2772-7.
1991: J Moss; S C Tsai; S R Price; DA Bobak; Martha Vaughan
Soluble guanine nucleotide-dependent ADP-ribosylation factors in activation of adenylyl cyclase by cholera toxin.
Methods in enzymology 1991;195():243-56.
1990: K C Williamson; L A Smith; Joel Moss; Martha Vaughan
Guanine nucleotide-dependent ADP-ribosylation of soluble rho catalyzed by Clostridium botulinum C3 ADP-ribosyltransferase. Isolation and characterization of a newly recognized form of rhoA.
The Journal of biological chemistry 1990;265(34):20807-12.
1990: S R Price; J J Murtagh; M Tsuchiya; I M Serventi; K P Van Meurs; C W Angus; Joel Moss; Martha Vaughan
Multiple forms of Go alpha mRNA: analysis of the 3'-untranslated regions.
Biochemistry 1990;29(21):5069-76.
1990: M Noda; S C Tsai; Ronald Adamik; Joel Moss; Martha Vaughan
Mechanism of cholera toxin activation by a guanine nucleotide-dependent 19 kDa protein.
Biochimica et biophysica acta 1990;1034(2):195-9.
1990: L Monaco; J J Murtagh; K B Newman; S C Tsai; Joel Moss; Martha Vaughan
Selective amplification of an mRNA and related pseudogene for a human ADP-ribosylation factor, a guanine nucleotide-dependent protein activator of cholera toxin.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(6):2206-10.
1990: K C Williamson; L A Smith; Joel Moss; Martha Vaughan
Role of guanine nucleotide-binding proteins in Clostridium botulinum pathology: purification of substrates for Clostridium botulinum C3 ADP-ribosyltransferase with different requirements for GTP and phospholipids.
Transactions of the Association of American Physicians 1990;103():281-8.
1990: Joel Moss; M Tsuchiya; S C Tsai; Ronald Adamik; DA Bobak; S R Price; M S Nightingale; Martha Vaughan
Structural and functional characterization of ADP-ribosylation factors, 20 kDa guanine nucleotide-binding proteins that activate cholera toxin.
Advances in second messenger and phosphoprotein research 1990;24():83-8.
1989: M Tsuchiya; S R Price; M S Nightingale; Joel Moss; Martha Vaughan
Tissue and species distribution of mRNA encoding two ADP-ribosylation factors, 20-kDa guanine nucleotide binding proteins.
Biochemistry 1989;28(25):9668-73.
1989: M Noda; S C Tsai; Ronald Adamik; DA Bobak; Joel Moss; Martha Vaughan
Activation of immobilized, biotinylated choleragen AI protein by a 19-kilodalton guanine nucleotide-binding protein.
Biochemistry 1989;28(19):7936-40.
1989: T D Bahnson; S C Tsai; Ronald Adamik; Joel Moss; Martha Vaughan
Microinjection of a 19-kDa guanine nucleotide-binding protein inhibits maturation of Xenopus oocytes.
The Journal of biological chemistry 1989;264(25):14824-8.
1989: DA Bobak; M S Nightingale; J J Murtagh; S R Price; Joel Moss; Martha Vaughan
Molecular cloning, characterization, and expression of human ADP-ribosylation factors: two guanine nucleotide-dependent activators of cholera toxin.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(16):6101-5.
1989: S R Price; S C Tsai; Ronald Adamik; C W Angus; I M Serventi; M Tsuchiya; Joel Moss; Martha Vaughan
Expression of Go alpha mRNA and protein in bovine tissues.
Biochemistry 1989;28(9):3803-7.
1989: Joel Moss; Martha Vaughan
Guanine nucleotide-binding proteins (G proteins) in activation of adenylyl cyclase: lessons learned from cholera and "travelers' diarrhea".
The Journal of laboratory and clinical medicine 1989;113(3):258-68.
1989: Martha Vaughan; S C Tsai; M Noda; Ronald Adamik; Joel Moss
Participation of a guanine nucleotide-binding protein cascade in cholera toxin activation of adenylate cyclase.
Journal of molecular and cellular cardiology 1989;21 Suppl 1():97-102.
1988: Y Kanaho; P P Chang; Joel Moss; Martha Vaughan
Mechanism of inhibition of transducin guanosine triphosphatase activity by vanadate.
The Journal of biological chemistry 1988;263(33):17584-9.
1988: S R Price; M Nightingale; S C Tsai; K C Williamson; Ronald Adamik; H C Chen; Joel Moss; Martha Vaughan
Guanine nucleotide-binding proteins that enhance choleragen ADP-ribosyltransferase activity: nucleotide and deduced amino acid sequence of an ADP-ribosylation factor cDNA.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(15):5488-91.
1988: S C Tsai; M Noda; Ronald Adamik; P P Chang; H C Chen; Joel Moss; Martha Vaughan
Stimulation of choleragen enzymatic activities by GTP and two soluble proteins purified from bovine brain.
The Journal of biological chemistry 1988;263(4):1768-72.
1988: J J Murtagh; S R Price; K P Van Meurs; C W Angus; Joel Moss; Martha Vaughan
Signal transduction by guanine nucleotide-binding proteins: possible molecular basis for multiple forms of Go alpha mRNA.
Transactions of the Association of American Physicians 1988;101():235-41.
1988: Joel Moss; Martha Vaughan
ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins.
Advances in enzymology and related areas of molecular biology 1988;61():303-79.
1987: K P Van Meurs; C W Angus; S Lavu; H F Kung; S K Czarnecki; Joel Moss; Martha Vaughan
Deduced amino acid sequence of bovine retinal Go alpha: similarities to other guanine nucleotide-binding proteins.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(10):3107-11.
1987: JANE HALPERN; P P Chang; S C Tsai; Ronald Adamik; Y Kanaho; R Sohn; Joel Moss; Martha Vaughan
Production of antibodies against rhodopsin after immunization with beta gamma-subunits of transducin: evidence for interaction of beta gamma-subunits of guanosine 5'-triphosphate binding proteins with receptor.
Biochemistry 1987;26(6):1655-8.
1986: C W Angus; K P Van Meurs; S C Tsai; Ronald Adamik; M C Miedel; Y C Pan; H F Kung; Joel Moss; Martha Vaughan
Identification of the probable site of choleragen-catalyzed ADP-ribosylation in a Go alpha-like protein based on cDNA sequence.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(16):5813-6.
1986: JANE HALPERN; S C Tsai; Ronald Adamik; Y Kanaho; E Bekesi; H F Kung; Joel Moss; Martha Vaughan
Structural and functional characterization of guanyl nucleotide-binding proteins using monoclonal antibodies to the alpha-subunit of transducin.
Molecular pharmacology 1986;29(5):515-9.
1985: Joel Moss; S C Tsai; P Bruni; Ronald Adamik; Y Kanaho; E L Hewlett; Martha Vaughan
Pertussis toxin-catalyzed ADP-ribosylation of adenylate cyclase. Effects of guanyl nucleotides and rhodopsin.
Developments in biological standardization 1985;61():43-9.
1985: P P Chang; JANE HALPERN; R L Sohn; Y Kanaho; Joel Moss; Martha Vaughan
Coupling of receptors to signal transducing components: use of anti-idiotypic antibodies to map the specific sites of interaction of receptors and guanyl nucleotide-binding proteins.
Transactions of the Association of American Physicians 1985;98():131-5.
1984: Y Kanaho; S C Tsai; Ronald Adamik; E L Hewlett; Joel Moss; Martha Vaughan
Rhodopsin-enhanced GTPase activity of the inhibitory GTP-binding protein of adenylate cyclase.
The Journal of biological chemistry 1984;259(12):7378-81.
1982: Joel Moss; Drusilla L Burns; P P Chang; A F Cutilletta; Martha Vaughan
Characterization of the GTP-binding component of the adenylate cyclase system in isolated myocardial muscle cells.
Journal of molecular and cellular cardiology 1982;14 Suppl 3():71-5.